Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map - Quiz - MDSpire

Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map

  • By

  • Catherine Sowerby

  • Adrienne Landsteiner

  • Kristen Ullman

  • Maylen Anthony

  • Caleb Kalinowski

  • Michele R. Spoont

  • Scott Sponheim

  • Kelvin Lim

  • Jose V. Pardo

  • Timothy J. Wilt

  • Wei Duan-Porter

  • May 6, 2026

Share

Original Source(s)

Neuroimaging and neurophysiologic biomarkers for diagnosis and prognosis of depressive disorders, bipolar disorder, anxiety disorders, obsessive compulsive disorder, posttraumatic stress disorder, and substance use disorder: an evidence map

  • by Catherine Sowerby, Adrienne Landsteiner, Kristen Ullman, Maylen Anthony, Caleb Kalinowski, Michele R. Spoont, Scott Sponheim, Kelvin Lim, Jose V. Pardo, Timothy J. Wilt, Wei Duan-Porter

  • May 6, 2026

Related Content

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

AI Platform Linked to Modest Anxiety Improvements

Randomized trial shows small symptom reductions vs group therapy and control, with outcomes shaped by worsening scores in comparator arms

Anxiety Often Missed in Primary Care

A narrative review outlines screening pathways, diagnostic challenges, and treatment strategies, including integrated care models and medication selection.